RU94039288A - Linear peptides, method of their synthesis, pharmaceutical composition and method of its preparing - Google Patents

Linear peptides, method of their synthesis, pharmaceutical composition and method of its preparing

Info

Publication number
RU94039288A
RU94039288A RU94039288/04A RU94039288A RU94039288A RU 94039288 A RU94039288 A RU 94039288A RU 94039288/04 A RU94039288/04 A RU 94039288/04A RU 94039288 A RU94039288 A RU 94039288A RU 94039288 A RU94039288 A RU 94039288A
Authority
RU
Russia
Prior art keywords
synthesis
linear peptides
peptides
preparing
pharmaceutical composition
Prior art date
Application number
RU94039288/04A
Other languages
Russian (ru)
Inventor
Йончик Альфред
De]
Фелдинг-Хаберманн Брунхильде
Дифенбах Беате
Риппманн Фридрих
Original Assignee
Мерк Патент ГмбХ (DE)
Мерк Патент Гмбх
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Мерк Патент ГмбХ (DE), Мерк Патент Гмбх filed Critical Мерк Патент ГмбХ (DE)
Publication of RU94039288A publication Critical patent/RU94039288A/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C07K7/04—Linear peptides containing only normal peptide links
    • C07K7/08—Linear peptides containing only normal peptide links having 12 to 20 amino acids
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/08—Vasodilators for multiple indications
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01D—SEPARATION
    • B01D15/00—Separating processes involving the treatment of liquids with solid sorbents; Apparatus therefor
    • B01D15/08—Selective adsorption, e.g. chromatography
    • B01D15/26—Selective adsorption, e.g. chromatography characterised by the separation mechanism
    • B01D15/38—Selective adsorption, e.g. chromatography characterised by the separation mechanism involving specific interaction not covered by one or more of groups B01D15/265 - B01D15/36
    • B01D15/3804—Affinity chromatography
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K1/00—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length
    • C07K1/14—Extraction; Separation; Purification
    • C07K1/16—Extraction; Separation; Purification by chromatography
    • C07K1/22—Affinity chromatography or related techniques based upon selective absorption processes
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
    • C07K14/70546—Integrin superfamily
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/745—Blood coagulation or fibrinolysis factors
    • C07K14/75—Fibrinogen
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Abstract

FIELD: organic chemistry, peptides. SUBSTANCE: product: linear peptides of the formula: X-A-Cys-(R)-B-Z where A, B, R, X and Z have values indicated in claim 1 of invention. Synthesized peptides are effective inhibitors of platelet integrine GP IIb IIIa (β) binding with natural ligands and can be used in cardiology and oncology (thrombosis, heart infarction, sclerosis, tumors, etc. ) and promotes wound healing also. EFFECT: improved method of synthesis, high curative effectiveness.

Claims (1)

Линейные пептиды общей формулы, приведенной в описании, являются эффективными ингибиторами связывания тромбоцитного интегрина GР ПвIIIа природными лигандами, между прочим, пригодны для профилактики и лечения заболевания круга кровообращения в случае тромбоза, инфаркта сердца, коронарных заболеваний сердца, артерио- и атеросклероза, опухолей, остеолитических заболеваний и действуют поддерживающе при процессах заживления ран.Linear peptides of the general formula given in the description are effective inhibitors of the binding of platelet integrin GR PvIIIa to natural ligands, among other things, they are suitable for the prevention and treatment of circulatory diseases in case of thrombosis, heart infarction, coronary heart disease, arterio- and atherosclerosis, tumors, osteolytic diseases and have a supportive effect on wound healing processes.
RU94039288/04A 1993-10-28 1994-10-27 Linear peptides, method of their synthesis, pharmaceutical composition and method of its preparing RU94039288A (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DEP4336758.5 1993-10-28
DE4336758A DE4336758A1 (en) 1993-10-28 1993-10-28 Linear Adhesion Inhibitors

Publications (1)

Publication Number Publication Date
RU94039288A true RU94039288A (en) 1996-09-10

Family

ID=6501202

Family Applications (1)

Application Number Title Priority Date Filing Date
RU94039288/04A RU94039288A (en) 1993-10-28 1994-10-27 Linear peptides, method of their synthesis, pharmaceutical composition and method of its preparing

Country Status (16)

Country Link
US (1) US5747457A (en)
EP (1) EP0655462B1 (en)
JP (1) JPH07149794A (en)
KR (1) KR950011466A (en)
CN (1) CN1107159A (en)
AT (1) ATE165837T1 (en)
AU (1) AU690923B2 (en)
CA (1) CA2134418A1 (en)
CZ (1) CZ265594A3 (en)
DE (2) DE4336758A1 (en)
HU (1) HUT69179A (en)
NO (1) NO944093L (en)
PL (1) PL305632A1 (en)
RU (1) RU94039288A (en)
SK (1) SK130094A3 (en)
ZA (1) ZA948479B (en)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CZ293323B6 (en) * 1995-08-30 2004-04-14 G. D. Searle & Co. Meta-guanidine, urea, thiourea or azacyclic amino benzoic acid derivatives as integrin antagonists
US6100423A (en) * 1995-08-30 2000-08-08 G. D. Searle & Co. Amino benzenepropanoic acid compounds and derivatives thereof
DE19534016A1 (en) * 1995-09-14 1997-03-20 Merck Patent Gmbh Biotin derivatives
IL143901A0 (en) 1998-12-23 2002-04-21 Searle & Co Use of cyclooxygenase-2- inhibitor, a matrix metallaproteinase inhibitor, an antineoplastic agent and optionally radiation as a combination treatment of neoplasia
ES2436170T3 (en) * 2003-12-03 2013-12-27 The Scripps Research Institute Antibodies and peptides specific for integrin alfa II beta3
CN108203465B (en) * 2016-12-20 2022-09-02 山西医科大学 Polypeptide with stable properties and capable of inhibiting tumor cells and tumor blood vessels in dual-targeting manner

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2799670A (en) * 1954-04-13 1957-07-16 Laufer Louis Method of preparing cysteinylglycine
US4177277A (en) * 1977-01-17 1979-12-04 E. R. Squibb & Sons, Inc. Method for alleviating hypertension
JP2945680B2 (en) * 1988-09-09 1999-09-06 旭硝子株式会社 Peptide derivatives and their uses
JPH02275899A (en) * 1989-02-09 1990-11-09 Merck & Co Inc Polypeptide synthesis
AU5939890A (en) * 1989-06-07 1991-01-07 Genentech Inc. Platelet aggregation inhibitors and related molecules

Also Published As

Publication number Publication date
NO944093D0 (en) 1994-10-27
DE59405893D1 (en) 1998-06-10
EP0655462B1 (en) 1998-05-06
ATE165837T1 (en) 1998-05-15
US5747457A (en) 1998-05-05
JPH07149794A (en) 1995-06-13
CA2134418A1 (en) 1995-04-29
ZA948479B (en) 1995-06-20
CN1107159A (en) 1995-08-23
CZ265594A3 (en) 1995-07-12
KR950011466A (en) 1995-05-15
AU690923B2 (en) 1998-05-07
EP0655462A1 (en) 1995-05-31
SK130094A3 (en) 1995-05-10
PL305632A1 (en) 1995-05-02
HUT69179A (en) 1995-08-28
DE4336758A1 (en) 1995-05-04
AU7750194A (en) 1995-05-18
NO944093L (en) 1995-05-02
HU9403100D0 (en) 1994-12-28

Similar Documents

Publication Publication Date Title
RU95108385A (en) Peptides, method of their synthesis, pharmaceutical composition and method of its preparing
ATE152910T1 (en) USE OF TAXOL IN THE PRODUCTION OF A MEDICINAL PRODUCT FOR THE TREATMENT OF CANCER
IL127352A (en) Pyridyl alkene- and pyridyl alkine-acid amides and pharmaceutical compositions containing them
BR9909358A (en) Compound, pharmaceutical composition, and, process to prevent or alleviate chronic complications resulting from diabetes mellitus
RU94031102A (en) Sulfides as endotheelin antagonists, and process for treating corresponding diseases
RU94029662A (en) Taxane derivative phosphonohydroxymethyl esters, pharmaceutical composition, treatment methods
RU94040163A (en) Heterocyclic derivatives of carboxylic acid and their salts and pharmaceutical composition exhibiting antifibrotic activity or activity inhibiting prolylhydroxylase or collagen biosynthesis
NO20000412L (en) Dipeptide compounds that inhibit leukocyte adhesion mediated by VLA-4
RU94045141A (en) Heterocyclic derivatives of carboxylic acid and their salts and pharmaceutical composition showing antifibrotic or prolylhydroxylase-inhibiting activity or collagen biosynthesis inhibition
RU94035686A (en) 4-arylaminobenzopyrane and related compounds, pharmaceutical composition, treatment method
RU94040170A (en) Isoquinolines
HU894581D0 (en) Alkoxy-4(1h)-pyridone derivatives, process for producing these compounds and pharmaceutical preparatives containing them as active substance
DE69715439D1 (en) PYRIDYLALKANIC ACID AMIDES AS CYTOSTATICS AND IMMUNOSUPRESSIVE MEDICINAL PRODUCTS
RU95106821A (en) Cyclopeptides, method of their synthesis, pharmaceutical composition and method of its preparing
RU94036761A (en) Derivatives of galanthamine and pharmaceutical composition
RU94044534A (en) Thiazole amino derivatives, processes for preparation thereof and pharmaceutical compositions containing said derivatives
RU94039288A (en) Linear peptides, method of their synthesis, pharmaceutical composition and method of its preparing
DE69410614D1 (en) BIS-NAPHTHALIMIDES FOR TREATMENT OF CANCER
AU7669391A (en) Novel cyclopropyl squalene derivatives and their use as inhibitors of cholesterol synthesis
RU94000064A (en) New 2-cyano-3-hydroxypropeneamides, method of preparing thereof, and pharmaceutical compositions containing said compounds
ES2128313T3 (en) N-SUBSTITUTED NAFTALIMIDES, THEIR OBTAINING AND EMPLOYMENT.
RU95109891A (en) 19,11-overbriged 4-estrenes, method for their production, pharmaceutical composition comprising them and intermediate compounds for their production
RU95105159A (en) 3-carboxaldehyde derivatives of quinoline and naphthyridine, antibacterial composition, method of treatment
RU95109874A (en) Heterocyclylhydroxybenzoylguanidines, method of their synthesis, pharmaceutical composition containing thereof and method of its preparing
DE69420574T2 (en) DERIVATIVES OF THERAPEUTICALLY EFFECTIVE PEPTIDES IN THE BLOOD COLLECTING CASCADE, METHOD FOR THE PRODUCTION AND PHARMACEUTICAL PREPARATIONS CONTAINING THE SAME